{"id":8405,"date":"2026-04-10T10:30:21","date_gmt":"2026-04-10T08:30:21","guid":{"rendered":"https:\/\/olpha.eu\/?p=8405"},"modified":"2026-04-10T10:30:23","modified_gmt":"2026-04-10T08:30:23","slug":"olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication","status":"publish","type":"post","link":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/","title":{"rendered":"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Cardiovascular diseases are the leading cause of death and disability in the EU. Approximately 1.8 million people die from them each year. The new generic prescription medicine by \u201cOlpha\u201d reduces the formation of blood clots, which can lead to life-threatening heart attacks or strokes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThe development of generic medicines, which is our current focus, is essential both in the interests of patients and for strengthening the resilience of the entire healthcare system. The entry of new products into the market and increasing competition bring clear benefits\u2014they improve access to medicines, provide doctors and pharmacists with broader choices in patient care, and, in Latvia\u2019s case, also reduce the high dependence on imported medicines. At the same time, every medicine offered by Latvian manufacturers makes a significant economic contribution by strengthening the local pharmaceutical industry and increasing the resilience of the national healthcare system,\u201d emphasizes AS \u201cOlpha\u201d Chairman of the Board, Dr. chem. Juris Hme\u013c\u0146ickis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With its new generic medicine, \u201cOlpha\u201d has won a public procurement tender in Italy\u2019s Marche region for supplying medicines to its hospitals over the next three years.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Latvian pharmaceutical manufacturer AS \u201cOlpha\u201d has launched its fourth generic cardiology product within two years. Currently, these medicines produced by AS \u201cOlpha\u201d have entered the pharmaceutical markets of seven European Union (EU) countries, including Latvia, Lithuania, and Estonia.<\/p>\n","protected":false},"author":4,"featured_media":8403,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-8405","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication - Olpha<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication - Olpha\" \/>\n<meta property=\"og:description\" content=\"Latvian pharmaceutical manufacturer AS \u201cOlpha\u201d has launched its fourth generic cardiology product within two years. Currently, these medicines produced by AS \u201cOlpha\u201d have entered the pharmaceutical markets of seven European Union (EU) countries, including Latvia, Lithuania, and Estonia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\" \/>\n<meta property=\"og:site_name\" content=\"Olpha\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OlphaLatvia\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-10T08:30:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-10T08:30:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Olpha\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\"},\"author\":{\"name\":\"Olpha\",\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/person\/200e1aea5c3cf6a2c68b0ac015c48875\"},\"headline\":\"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication\",\"datePublished\":\"2026-04-10T08:30:21+00:00\",\"dateModified\":\"2026-04-10T08:30:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\"},\"wordCount\":195,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/olpha.eu\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg\",\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\",\"url\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\",\"name\":\"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication - Olpha\",\"isPartOf\":{\"@id\":\"https:\/\/olpha.eu\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg\",\"datePublished\":\"2026-04-10T08:30:21+00:00\",\"dateModified\":\"2026-04-10T08:30:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage\",\"url\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg\",\"contentUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg\",\"width\":2560,\"height\":1706},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/olpha.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/olpha.eu\/en\/#website\",\"url\":\"https:\/\/olpha.eu\/en\/\",\"name\":\"Olpha\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/olpha.eu\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/olpha.eu\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/olpha.eu\/en\/#organization\",\"name\":\"Olpha\",\"url\":\"https:\/\/olpha.eu\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg\",\"contentUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg\",\"width\":1,\"height\":1,\"caption\":\"Olpha\"},\"image\":{\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OlphaLatvia\",\"https:\/\/instagram.com\/olphalatvia\",\"https:\/\/www.linkedin.com\/company\/OlphaGlobal\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/person\/200e1aea5c3cf6a2c68b0ac015c48875\",\"name\":\"Olpha\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/5bd175147c02c4a94f09844e5bf57ed055d39620e1000c48df5b36b0cf969cf8?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5bd175147c02c4a94f09844e5bf57ed055d39620e1000c48df5b36b0cf969cf8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5bd175147c02c4a94f09844e5bf57ed055d39620e1000c48df5b36b0cf969cf8?s=96&d=mm&r=g\",\"caption\":\"Olpha\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication - Olpha","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/","og_locale":"en_US","og_type":"article","og_title":"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication - Olpha","og_description":"Latvian pharmaceutical manufacturer AS \u201cOlpha\u201d has launched its fourth generic cardiology product within two years. Currently, these medicines produced by AS \u201cOlpha\u201d have entered the pharmaceutical markets of seven European Union (EU) countries, including Latvia, Lithuania, and Estonia.","og_url":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/","og_site_name":"Olpha","article_publisher":"https:\/\/www.facebook.com\/OlphaLatvia","article_published_time":"2026-04-10T08:30:21+00:00","article_modified_time":"2026-04-10T08:30:23+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg","type":"image\/jpeg"}],"author":"Olpha","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#article","isPartOf":{"@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/"},"author":{"name":"Olpha","@id":"https:\/\/olpha.eu\/en\/#\/schema\/person\/200e1aea5c3cf6a2c68b0ac015c48875"},"headline":"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication","datePublished":"2026-04-10T08:30:21+00:00","dateModified":"2026-04-10T08:30:23+00:00","mainEntityOfPage":{"@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/"},"wordCount":195,"commentCount":0,"publisher":{"@id":"https:\/\/olpha.eu\/en\/#organization"},"image":{"@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage"},"thumbnailUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg","articleSection":["Press"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/","url":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/","name":"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication - Olpha","isPartOf":{"@id":"https:\/\/olpha.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage"},"image":{"@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage"},"thumbnailUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg","datePublished":"2026-04-10T08:30:21+00:00","dateModified":"2026-04-10T08:30:23+00:00","breadcrumb":{"@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#primaryimage","url":"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg","contentUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2026\/04\/Olpha-scaled.jpg","width":2560,"height":1706},{"@type":"BreadcrumbList","@id":"https:\/\/olpha.eu\/en\/olpha-strengthens-its-position-in-europe-with-a-new-generic-cardiology-medication\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/olpha.eu\/en\/"},{"@type":"ListItem","position":2,"name":"\u201cOlpha\u201d strengthens its position in Europe with a new generic cardiology medication"}]},{"@type":"WebSite","@id":"https:\/\/olpha.eu\/en\/#website","url":"https:\/\/olpha.eu\/en\/","name":"Olpha","description":"","publisher":{"@id":"https:\/\/olpha.eu\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olpha.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/olpha.eu\/en\/#organization","name":"Olpha","url":"https:\/\/olpha.eu\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/","url":"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg","contentUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg","width":1,"height":1,"caption":"Olpha"},"image":{"@id":"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OlphaLatvia","https:\/\/instagram.com\/olphalatvia","https:\/\/www.linkedin.com\/company\/OlphaGlobal"]},{"@type":"Person","@id":"https:\/\/olpha.eu\/en\/#\/schema\/person\/200e1aea5c3cf6a2c68b0ac015c48875","name":"Olpha","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5bd175147c02c4a94f09844e5bf57ed055d39620e1000c48df5b36b0cf969cf8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5bd175147c02c4a94f09844e5bf57ed055d39620e1000c48df5b36b0cf969cf8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5bd175147c02c4a94f09844e5bf57ed055d39620e1000c48df5b36b0cf969cf8?s=96&d=mm&r=g","caption":"Olpha"}}]}},"_links":{"self":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts\/8405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/comments?post=8405"}],"version-history":[{"count":1,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts\/8405\/revisions"}],"predecessor-version":[{"id":8406,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts\/8405\/revisions\/8406"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/media\/8403"}],"wp:attachment":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/media?parent=8405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/categories?post=8405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/tags?post=8405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}